基本信息 产品详情 公司简介 推荐产品
网站主页 Concizumab
  • (Concizumab)Biosimilar Reference Antibody-GS40146
  • (Concizumab)Biosimilar Reference Antibody-GS40146
  • (Concizumab)Biosimilar Reference Antibody-GS40146

1/3

(Concizumab)Biosimilar Reference Antibody-GS40146 新品

Concizumab
300 100μg 起订
湖北 更新日期:2026-03-10

武汉迈思生物科技有限公司

VIP1年
联系人:市场
电话:027-65523427拨打
手机:18007167883 拨打
邮箱:Service@mabnus.com

产品详情:

英文名称:
Concizumab
CAS号:
1312299-39-0
品牌:
Mabnus
产地:
武汉
保存条件:
store at -20°C or -80°C. Avoid repeated freeze.
纯度规格:
>95% by SDS-PAGE
重组:
应用:
ELISA;FC;Functional Assays;IF
种属反应性:
Human
宿主:
Humanised
偶联物:
靶点:
TFPI
免疫原:
TFPI
亚型:
IgG4 - kappa
验证方法:
(Concizumab)Biosimilar Reference Antibody(GS40146) on SDS-PAGE under non-reducing (NR) and reducing (R) condition.

货号:GS40146

Concizumab is an investigational humanized monoclonal antibody developed as a novel prophylactic treatment for hemophilia A and B, regardless of inhibitor status. It represents a new class of therapy known as an anti-TFPI (tissue factor pathway inhibitor) antibody. Unlike traditional factor replacement therapies, concizumab works by modulating the body's own natural coagulation pathway to enhance thrombin generation. It is administered via subcutaneous injection, offering a significant convenience advantage over intravenous factor products. Clinical trials have demonstrated its potential to reduce bleeding episodes effectively.


Concizumab;

公司简介

武汉迈思生物科技有限公司立足于解决行业内功能活性蛋白表达及高亲和力、高灵敏度抗体开发难的痛点,依托自建的两大核心技术平台:哺乳动物细胞蛋白表达平台和单个B细胞抗体开发平台,竭诚为广大科研机构、高等院校、IVD企业、医药企业等提供一站式蛋白表达及抗体开发相关产品和技术服务。

成立日期 (5年)
注册资本 壹佰伍拾万圆人民币
员工人数 10-50人
年营业额 ¥ 100万以内
经营模式 试剂
主营行业 抗体,蛋白组学

Concizumab相关厂家报价

内容声明
拨打电话 立即询价